Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure
暂无分享,去创建一个
E. Lonn | R. Wachter | M. Senni | K. Witte | A. Noè | D. Pascual-Figal | E. Straburzyńska-Migaj | C. Fonseca | J. Bělohlávek | Y. Chiang | H. Schwende | D. Butylin | Adele Noè
[1] M. Link,et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2022, Journal of the American College of Cardiology.
[2] Dave L Dixon,et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. , 2022, Journal of cardiac failure.
[3] M. Vaduganathan,et al. Optimizing Foundational Therapies in Patients With HFrEF , 2022, JACC. Basic to translational science.
[4] G. Linssen,et al. Diabetes and treatment of chronic heart failure in a large real‐world heart failure population , 2021, ESC heart failure.
[5] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[6] M. Metra,et al. Best of European Journal of Heart Failure at the ESC/HFA Heart Failure Congress 2021 , 2021, European journal of heart failure.
[7] J. Kautzner,et al. The effect of three major co‐morbidities on quality of life and outcome of patients with heart failure with reduced ejection fraction , 2021, ESC heart failure.
[8] G. Fonarow,et al. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. , 2021, Journal of the American College of Cardiology.
[9] R. Wachter,et al. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study. , 2020, JACC. Heart failure.
[10] J. H. Patterson,et al. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry. , 2020, JACC. Heart failure.
[11] E. Lonn,et al. Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study , 2019, European journal of heart failure.
[12] E. Lonn,et al. Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study , 2019, European journal of heart failure.
[13] A. Hoes,et al. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. , 2019, JACC. Heart failure.
[14] J. Jefferies,et al. Are Guidelines Merely Suggestions? , 2018, Journal of the American College of Cardiology.
[15] J. H. Patterson,et al. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. , 2018, Journal of the American College of Cardiology.
[16] G. Filippatos,et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology , 2018, European journal of heart failure.
[17] R. Wachter,et al. Rationale and design of TRANSITION: a randomized trial of pre‐discharge vs. post‐discharge initiation of sacubitril/valsartan , 2017, ESC heart failure.
[18] M. Kearney,et al. Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes , 2017, Diabetes Care.
[19] J. Atherton,et al. Expert Comment: Is Medication Titration in Heart Failure too Complex? , 2016, Cardiac failure review.
[20] Akshay S. Desai,et al. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure. , 2016, Journal of the American College of Cardiology.
[21] Mark D. Huffman,et al. Association between diabetes mellitus and post‐discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial , 2013, European journal of heart failure.
[22] Christiane,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.